135 related articles for article (PubMed ID: 7692883)
1. Nevirapine synergistically inhibits HIV-1 replication in combination with zidovudine, interferon or CD4 immunoadhesin.
Koup RA; Brewster F; Grob P; Sullivan JL
AIDS; 1993 Sep; 7(9):1181-4. PubMed ID: 7692883
[TBL] [Abstract][Full Text] [Related]
2. BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine.
Richman D; Rosenthal AS; Skoog M; Eckner RJ; Chou TC; Sabo JP; Merluzzi VJ
Antimicrob Agents Chemother; 1991 Feb; 35(2):305-8. PubMed ID: 1708976
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of human immunodeficiency virus type 1 in vitro by a non-nucleoside reverse transcriptase inhibitor MKC-442, alone and in combination with other anti-HIV compounds.
Brennan TM; Taylor DL; Bridges CG; Leyda JP; Tyms AS
Antiviral Res; 1995 Mar; 26(2):173-87. PubMed ID: 7541619
[TBL] [Abstract][Full Text] [Related]
4. Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A.
Johnson VA; Barlow MA; Merrill DP; Chou TC; Hirsch MS
J Infect Dis; 1990 Jun; 161(6):1059-67. PubMed ID: 2345291
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.
Koup RA; Merluzzi VJ; Hargrave KD; Adams J; Grozinger K; Eckner RJ; Sullivan JL
J Infect Dis; 1991 May; 163(5):966-70. PubMed ID: 1708400
[TBL] [Abstract][Full Text] [Related]
6. Lamivudine or stavudine in two- and three-drug combinations against human immunodeficiency virus type 1 replication in vitro.
Merrill DP; Moonis M; Chou TC; Hirsch MS
J Infect Dis; 1996 Feb; 173(2):355-64. PubMed ID: 8568296
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells.
Okamoto M; Okamoto T; Baba M
Antimicrob Agents Chemother; 1999 Mar; 43(3):492-7. PubMed ID: 10049256
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.
Merluzzi VJ; Hargrave KD; Labadia M; Grozinger K; Skoog M; Wu JC; Shih CK; Eckner K; Hattox S; Adams J
Science; 1990 Dec; 250(4986):1411-3. PubMed ID: 1701568
[TBL] [Abstract][Full Text] [Related]
9. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
[TBL] [Abstract][Full Text] [Related]
10. Three-drug synergistic inhibition of HIV-1 replication in vitro by 3'-fluoro-3'-deoxythymidine, recombinant soluble CD4, and recombinant interferon-alpha.
Pan XZ; Qiu ZD; Baron PA; Gold JW; Polsky B; Chou TC; Armstrong D
AIDS Res Hum Retroviruses; 1992 May; 8(5):589-95. PubMed ID: 1515212
[TBL] [Abstract][Full Text] [Related]
11. Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro.
Johnson VA; Merrill DP; Videler JA; Chou TC; Byington RE; Eron JJ; D'Aquila RT; Hirsch MS
J Infect Dis; 1991 Oct; 164(4):646-55. PubMed ID: 1716649
[TBL] [Abstract][Full Text] [Related]
12. Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3'-azido-3'-deoxythymidine.
Johnson VA; Barlow MA; Chou TC; Fisher RA; Walker BD; Hirsch MS; Schooley RT
J Infect Dis; 1989 May; 159(5):837-44. PubMed ID: 2785146
[TBL] [Abstract][Full Text] [Related]
13. Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro.
Chong KT; Pagano PJ; Hinshaw RR
Antimicrob Agents Chemother; 1994 Feb; 38(2):288-93. PubMed ID: 7514857
[TBL] [Abstract][Full Text] [Related]
14. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibition of human immunodeficiency virus type 1 by a combination of delavirdine (U-90152) with protease inhibitor U-75875 or interferon-alpha.
Pagano PJ; Chong KT
J Infect Dis; 1995 Jan; 171(1):61-7. PubMed ID: 7528253
[TBL] [Abstract][Full Text] [Related]
16. In vitro comparison of selected triple-drug combinations for suppression of HIV-1 replication: the Inter-Company Collaboration Protocol.
St Clair MH; Pennington KN; Rooney J; Barry DW
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S83-91. PubMed ID: 7552518
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus type 1 replication in vitro by the bisheteroarylpiperazine atevirdine (U-87201E) in combination with zidovudine or didanosine.
Campbell TB; Young RK; Eron JJ; D'Aquila RT; Tarpley WG; Kuritzkes DR
J Infect Dis; 1993 Aug; 168(2):318-26. PubMed ID: 7687641
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 (HIV-1) inhibitory interactions between protease inhibitor Ro 31-8959 and zidovudine, 2',3'-dideoxycytidine, or recombinant interferon-alpha A against zidovudine-sensitive or -resistant HIV-1 in vitro.
Johnson VA; Merrill DP; Chou TC; Hirsch MS
J Infect Dis; 1992 Nov; 166(5):1143-6. PubMed ID: 1328402
[TBL] [Abstract][Full Text] [Related]
19. Differential alteration of the anti-HIV-1 effect of phosphorothioate oligonucleotide S-dC28 by AZT, interferon-alpha, and dextran sulfate.
Chou TC; Zhu QY; Stein CA
AIDS Res Hum Retroviruses; 1991 Nov; 7(11):943-51. PubMed ID: 1760231
[TBL] [Abstract][Full Text] [Related]
20. Complete inhibition of viral breakthrough by combination of MKC-442 with AZT during a long-term culture of HIV-1 infected cells.
Okamoto M; Makino M; Yamada K; Nakade K; Yuasa S; Baba M
Antiviral Res; 1996 Jun; 31(1-2):69-77. PubMed ID: 8793010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
